Financhill
Sell
46

ILMN Quote, Financials, Valuation and Earnings

Last price:
$80.55
Seasonality move :
6.11%
Day range:
$78.89 - $80.67
52-week range:
$68.70 - $156.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.96x
P/B ratio:
5.38x
Volume:
2M
Avg. volume:
2.1M
1-year change:
-23.02%
Market cap:
$12.7B
Revenue:
$4.4B
EPS (TTM):
-$6.07

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ILMN
Illumina
$1B $0.94 -5.72% 430.2% $106.53
CTSO
CytoSorbents
$9M -$0.07 10.68% -41.38% $5.00
DCTH
Delcath Systems
$16.8M $0.03 179.13% -93.78% $23.17
EXAS
Exact Sciences
$688.6M -$0.10 10.52% -84.17% $68.83
NTRA
Natera
$446.7M -$0.66 15.16% -106.89% $191.91
STRR
Star Equity Holdings
$16.4M -$0.25 18.67% -43.28% $8.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ILMN
Illumina
$80.54 $106.53 $12.7B -- $0.00 0% 2.96x
CTSO
CytoSorbents
$0.85 $5.00 $53.2M -- $0.00 0% 1.35x
DCTH
Delcath Systems
$16.15 $23.17 $562.4M -- $0.00 0% 9.92x
EXAS
Exact Sciences
$56.48 $68.83 $10.7B -- $0.00 0% 3.70x
NTRA
Natera
$152.48 $191.91 $20.8B -- $0.00 0% 10.68x
STRR
Star Equity Holdings
$2.17 $8.50 $7M 0.75x $0.00 0% 0.12x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ILMN
Illumina
45.66% 0.950 15.77% 1.34x
CTSO
CytoSorbents
49.38% 1.160 22.69% 1.98x
DCTH
Delcath Systems
-- 2.997 -- 13.86x
EXAS
Exact Sciences
49.21% 0.148 28.45% 2.12x
NTRA
Natera
6.09% 3.386 0.42% 3.58x
STRR
Star Equity Holdings
18.39% -0.314 40.47% 0.69x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ILMN
Illumina
$683M $164M -20.34% -34.38% 19.89% $201M
CTSO
CytoSorbents
$6.2M -$3.9M -58.93% -106.57% -10.01% -$3.5M
DCTH
Delcath Systems
$16.9M $642K -37.34% -40.28% 3.25% $2.1M
EXAS
Exact Sciences
$500.5M -$89.8M -19.08% -35.57% -13.04% -$365K
NTRA
Natera
$316.8M -$79.2M -15.3% -19.19% -13.1% $22.6M
STRR
Star Equity Holdings
$3.1M -$2.8M -13.58% -15.99% -22.03% $200K

Illumina vs. Competitors

  • Which has Higher Returns ILMN or CTSO?

    CytoSorbents has a net margin of 12.58% compared to Illumina's net margin of -16.94%. Illumina's return on equity of -34.38% beat CytoSorbents's return on equity of -106.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    ILMN
    Illumina
    65.61% $0.82 $4.4B
    CTSO
    CytoSorbents
    71.13% -$0.02 $28.7M
  • What do Analysts Say About ILMN or CTSO?

    Illumina has a consensus price target of $106.53, signalling upside risk potential of 32.27%. On the other hand CytoSorbents has an analysts' consensus of $5.00 which suggests that it could grow by 488.93%. Given that CytoSorbents has higher upside potential than Illumina, analysts believe CytoSorbents is more attractive than Illumina.

    Company Buy Ratings Hold Ratings Sell Ratings
    ILMN
    Illumina
    7 11 0
    CTSO
    CytoSorbents
    1 1 0
  • Is ILMN or CTSO More Risky?

    Illumina has a beta of 1.349, which suggesting that the stock is 34.945% more volatile than S&P 500. In comparison CytoSorbents has a beta of 1.171, suggesting its more volatile than the S&P 500 by 17.12%.

  • Which is a Better Dividend Stock ILMN or CTSO?

    Illumina has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CytoSorbents offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Illumina pays -- of its earnings as a dividend. CytoSorbents pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ILMN or CTSO?

    Illumina quarterly revenues are $1B, which are larger than CytoSorbents quarterly revenues of $8.7M. Illumina's net income of $131M is higher than CytoSorbents's net income of -$1.5M. Notably, Illumina's price-to-earnings ratio is -- while CytoSorbents's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina is 2.96x versus 1.35x for CytoSorbents. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ILMN
    Illumina
    2.96x -- $1B $131M
    CTSO
    CytoSorbents
    1.35x -- $8.7M -$1.5M
  • Which has Higher Returns ILMN or DCTH?

    Delcath Systems has a net margin of 12.58% compared to Illumina's net margin of 5.4%. Illumina's return on equity of -34.38% beat Delcath Systems's return on equity of -40.28%.

    Company Gross Margin Earnings Per Share Invested Capital
    ILMN
    Illumina
    65.61% $0.82 $4.4B
    DCTH
    Delcath Systems
    85.62% $0.03 $80.2M
  • What do Analysts Say About ILMN or DCTH?

    Illumina has a consensus price target of $106.53, signalling upside risk potential of 32.27%. On the other hand Delcath Systems has an analysts' consensus of $23.17 which suggests that it could grow by 43.45%. Given that Delcath Systems has higher upside potential than Illumina, analysts believe Delcath Systems is more attractive than Illumina.

    Company Buy Ratings Hold Ratings Sell Ratings
    ILMN
    Illumina
    7 11 0
    DCTH
    Delcath Systems
    4 0 0
  • Is ILMN or DCTH More Risky?

    Illumina has a beta of 1.349, which suggesting that the stock is 34.945% more volatile than S&P 500. In comparison Delcath Systems has a beta of 0.722, suggesting its less volatile than the S&P 500 by 27.805%.

  • Which is a Better Dividend Stock ILMN or DCTH?

    Illumina has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Illumina pays -- of its earnings as a dividend. Delcath Systems pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ILMN or DCTH?

    Illumina quarterly revenues are $1B, which are larger than Delcath Systems quarterly revenues of $19.8M. Illumina's net income of $131M is higher than Delcath Systems's net income of $1.1M. Notably, Illumina's price-to-earnings ratio is -- while Delcath Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina is 2.96x versus 9.92x for Delcath Systems. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ILMN
    Illumina
    2.96x -- $1B $131M
    DCTH
    Delcath Systems
    9.92x -- $19.8M $1.1M
  • Which has Higher Returns ILMN or EXAS?

    Exact Sciences has a net margin of 12.58% compared to Illumina's net margin of -14.32%. Illumina's return on equity of -34.38% beat Exact Sciences's return on equity of -35.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    ILMN
    Illumina
    65.61% $0.82 $4.4B
    EXAS
    Exact Sciences
    70.82% -$0.54 $4.7B
  • What do Analysts Say About ILMN or EXAS?

    Illumina has a consensus price target of $106.53, signalling upside risk potential of 32.27%. On the other hand Exact Sciences has an analysts' consensus of $68.83 which suggests that it could grow by 21.87%. Given that Illumina has higher upside potential than Exact Sciences, analysts believe Illumina is more attractive than Exact Sciences.

    Company Buy Ratings Hold Ratings Sell Ratings
    ILMN
    Illumina
    7 11 0
    EXAS
    Exact Sciences
    18 4 0
  • Is ILMN or EXAS More Risky?

    Illumina has a beta of 1.349, which suggesting that the stock is 34.945% more volatile than S&P 500. In comparison Exact Sciences has a beta of 0.920, suggesting its less volatile than the S&P 500 by 7.968%.

  • Which is a Better Dividend Stock ILMN or EXAS?

    Illumina has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Exact Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Illumina pays -- of its earnings as a dividend. Exact Sciences pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ILMN or EXAS?

    Illumina quarterly revenues are $1B, which are larger than Exact Sciences quarterly revenues of $706.8M. Illumina's net income of $131M is higher than Exact Sciences's net income of -$101.2M. Notably, Illumina's price-to-earnings ratio is -- while Exact Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina is 2.96x versus 3.70x for Exact Sciences. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ILMN
    Illumina
    2.96x -- $1B $131M
    EXAS
    Exact Sciences
    3.70x -- $706.8M -$101.2M
  • Which has Higher Returns ILMN or NTRA?

    Natera has a net margin of 12.58% compared to Illumina's net margin of -13.34%. Illumina's return on equity of -34.38% beat Natera's return on equity of -19.19%.

    Company Gross Margin Earnings Per Share Invested Capital
    ILMN
    Illumina
    65.61% $0.82 $4.4B
    NTRA
    Natera
    63.12% -$0.50 $1.3B
  • What do Analysts Say About ILMN or NTRA?

    Illumina has a consensus price target of $106.53, signalling upside risk potential of 32.27%. On the other hand Natera has an analysts' consensus of $191.91 which suggests that it could grow by 25.86%. Given that Illumina has higher upside potential than Natera, analysts believe Illumina is more attractive than Natera.

    Company Buy Ratings Hold Ratings Sell Ratings
    ILMN
    Illumina
    7 11 0
    NTRA
    Natera
    12 0 0
  • Is ILMN or NTRA More Risky?

    Illumina has a beta of 1.349, which suggesting that the stock is 34.945% more volatile than S&P 500. In comparison Natera has a beta of 1.794, suggesting its more volatile than the S&P 500 by 79.445%.

  • Which is a Better Dividend Stock ILMN or NTRA?

    Illumina has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Natera offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Illumina pays -- of its earnings as a dividend. Natera pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ILMN or NTRA?

    Illumina quarterly revenues are $1B, which are larger than Natera quarterly revenues of $501.8M. Illumina's net income of $131M is higher than Natera's net income of -$66.9M. Notably, Illumina's price-to-earnings ratio is -- while Natera's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina is 2.96x versus 10.68x for Natera. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ILMN
    Illumina
    2.96x -- $1B $131M
    NTRA
    Natera
    10.68x -- $501.8M -$66.9M
  • Which has Higher Returns ILMN or STRR?

    Star Equity Holdings has a net margin of 12.58% compared to Illumina's net margin of -9.1%. Illumina's return on equity of -34.38% beat Star Equity Holdings's return on equity of -15.99%.

    Company Gross Margin Earnings Per Share Invested Capital
    ILMN
    Illumina
    65.61% $0.82 $4.4B
    STRR
    Star Equity Holdings
    24.27% -$0.52 $73.2M
  • What do Analysts Say About ILMN or STRR?

    Illumina has a consensus price target of $106.53, signalling upside risk potential of 32.27%. On the other hand Star Equity Holdings has an analysts' consensus of $8.50 which suggests that it could grow by 291.72%. Given that Star Equity Holdings has higher upside potential than Illumina, analysts believe Star Equity Holdings is more attractive than Illumina.

    Company Buy Ratings Hold Ratings Sell Ratings
    ILMN
    Illumina
    7 11 0
    STRR
    Star Equity Holdings
    1 0 0
  • Is ILMN or STRR More Risky?

    Illumina has a beta of 1.349, which suggesting that the stock is 34.945% more volatile than S&P 500. In comparison Star Equity Holdings has a beta of 0.871, suggesting its less volatile than the S&P 500 by 12.92%.

  • Which is a Better Dividend Stock ILMN or STRR?

    Illumina has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Star Equity Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Illumina pays -- of its earnings as a dividend. Star Equity Holdings pays out -19.54% of its earnings as a dividend.

  • Which has Better Financial Ratios ILMN or STRR?

    Illumina quarterly revenues are $1B, which are larger than Star Equity Holdings quarterly revenues of $12.9M. Illumina's net income of $131M is higher than Star Equity Holdings's net income of -$1.2M. Notably, Illumina's price-to-earnings ratio is -- while Star Equity Holdings's PE ratio is 0.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Illumina is 2.96x versus 0.12x for Star Equity Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ILMN
    Illumina
    2.96x -- $1B $131M
    STRR
    Star Equity Holdings
    0.12x 0.75x $12.9M -$1.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

NVIDIA (NASDAQ:NVDA) and Broadcom (NASDAQ:AVGO) are two of the hottest…

Why Did Forge Global Stock Go Down?
Why Did Forge Global Stock Go Down?

Shares of Forge Global (NYSE:FRGE), a platform that allows accredited…

Is GlobalFoundries On The Verge Of A Breakout?
Is GlobalFoundries On The Verge Of A Breakout?

GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
66
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 45x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
54
AAP alert for May 23

Advance Auto Parts [AAP] is up 57.27% over the past day.

Buy
67
IONQ alert for May 23

IonQ [IONQ] is up 36.52% over the past day.

Sell
19
ENPH alert for May 23

Enphase Energy [ENPH] is down 19.62% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock